Allergan to move Botox into late-stage testing for depression

(Reuters) - Allergan plc said on Wednesday that its Botox blockbuster wrinkle treatment just missed achieving a significant improvement in treating depression in a mid-stage trial, but it found the data encouraging enough to move into larger Phase III testing.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Allergy | Botox | Depression | Health